Riparian Partners Research
Advisory Approach
Riparian Partners is a boutique middle-market M&A advisory firm based in Providence, Rhode Island, with over 30 years of institutional investment banking expertise. Founded in 1993 by Brendan VanDeventer, the firm operates on a thesis that middle-market business owners benefit from personalized, senior-level partner engagement combined with disciplined, institutional-quality transaction processes. The firm emphasizes confidentiality, objective counsel, and alignment of interests throughout the engagement lifecycle. Their approach reflects deep operational expertise—several partners have executive-level experience running businesses—which differentiates them from transactional-focused boutiques. The firm's sweet spot is founder-owned and family-held businesses valued between $5 million and $100 million where operational complexity, market positioning, or valuation uncertainty creates value from expert advisory guidance.
Track Record & Scale
Riparian has managed approximately 100+ principal engagement responsibilities over its 33-year history, representing greater than $1 billion in aggregate transaction value. This track record spans all major economic cycles, demonstrating execution capability through 2008-2009 financial crisis, the 2020 COVID disruption, and subsequent market volatility. The firm's longevity and consistency reflect strong client relationships and repeat mandates. Key transactions include the $73M sale of Cosmed Group (healthcare services) to STERIS in 2004, the sale of Sippican (marine and manufacturing services) to The Carlyle Group, and numerous middle-market transactions across manufacturing, healthcare, and distribution sectors.
Sector Focus
Riparian's practice concentrates on three core industrial/operational sectors: manufacturing (both discrete and process), healthcare services, and distribution/industrial services. Within manufacturing, the firm has particular depth in precision machining, contract manufacturing, specialty chemicals, industrial components, and building products. Their manufacturing expertise is grounded in operational understanding—the team includes former plant managers, COOs, and operational executives who can assess plant-level economics, capital efficiency, and growth potential. This operational credibility drives meaningful client value in valuation discussions and buyer positioning.
The healthcare services practice encompasses physician practice management, behavioral health platforms, medical device sterilization services, and healthcare-related staffing. The distribution practice covers electrical supply, automotive aftermarket, plumbing and heating supply, and specialty distribution channels. The firm also maintains active advisory practices in food & beverage processing, jewelry manufacturing, and specialty services businesses.
Process & Fee Structure
Riparian conducts institutional-quality sell-side and advisory processes with emphasis on confidentiality and buyer outreach. Typical engagement characteristics:
- Senior partner engagement throughout transaction lifecycle (MD-led, not junior associates)
- Personalized client management with focus on aligned incentives
- Disciplined, timely transaction management
- Work with integrated legal, tax, and accounting advisors
- Exclusive mandate for sell-side transactions
The firm does not publicly disclose detailed fee structures, but typical middle-market M&A advisory engagements in the $5M-$100M range typically involve retainer components (credited against success fees) and success fees scaled to transaction value. The firm accommodates various deal types including straight sales, recapitalizations, acquisitions for growth, and management-led transactions.
Buyer Network & Relationships
Riparian has deep relationships across multiple buyer categories. The firm has successfully closed transactions with major private equity firms (evidenced by Carlyle Group, Incline Equity Partners, Genstar Capital transactions), strategic acquirers across manufacturing and distribution, family offices, and specialized buyers in niche sectors. Through its acquisition by Oppenheimer & Co. in October 2020, the firm gained access to Oppenheimer's broader institutional network, expanding relationship reach within specialty finance and broader investment banking ecosystems. The firm's transaction history demonstrates strong connectivity to both regional and national buyer groups.
Competitive Positioning
Riparian differentiates through:
- Operational credibility: Multiple partners with prior C-suite and operating company experience, enabling credible value-creation conversations with buyers
- Senior engagement: Every engagement is managing partner-led, not delegated to junior staff
- Institutional experience: 30+ years through multiple economic cycles provides sophisticated process management and market knowledge
- Confidentiality and discretion: Strong emphasis on managing information flow and confidentiality throughout process
- Integrated advisory: Emphasis on working collaboratively with legal, tax, and accounting advisors rather than siloed advisory
- Relationship stability: Partnership structure with long-tenured principals (founder still active, partners with 15-30 years tenure)
Team
The firm has four active managing partners, each with 20-30+ years of experience:
Brendan P. VanDeventer (Founder, Managing Partner): Established Riparian in 1993 and remains actively engaged in transactions. Over 100 principal engagements, >$1B in aggregate transaction value. Background in structured financing, leveraged buyouts, and ESOPs. MBA Finance (Babson College), BS Business Administration (University of New Hampshire). Series 63 and 79 registered.
Robert E. Cramer (Managing Partner): 30+ years in financial services. Former Group Head and Managing Director of Financial Institutions and Real Estate Investment Banking at Oppenheimer & Co., leading national specialty finance practice. Prior roles include Head of Investment Banking at RBC Capital Markets Boston and Tucker Anthony Sutro. Teaching experience as adjunct finance instructor at Boston College's Carroll School. MBA (NYU Stern), MA (Middlebury College), BS (Bates College). Series 7 and 24 registered.
Thomas F. Golding (Managing Partner): 20+ years in financial industry with distribution business expertise. Former President and COO of Eagle Electric Supply Division at Sonepar Distribution US. Commercial lending background at Shawmut Bank. BA Economics (Williams College, 1982). Series 63 and 79 registered. Director of multiple private corporations.
Robert C. Rubino (Managing Partner): Joined Riparian in 2020 after 13+ years in C-suite roles at major financial institutions. Former executive at CIT Bank (Strategic Planning and M&A), Santander Bank, and Citizens Financial. Extensive experience executing strategic acquisitions, divestitures, and regulatory remediation. MA Economics (London School of Economics), BS Economics (Providence College). Series 24, 7, 79, and 63 registered.
Geographic Coverage
Primary focus on North America with strong coverage of Northeast (New England, Mid-Atlantic), Midwest (Ohio, Michigan, Illinois), and Southeast (Carolinas). Additional experience with cross-border transactions and transactions involving international buyers. Headquarters in Providence, Rhode Island with national reach through Oppenheimer network.
Institutional Affiliation
Acquired by Oppenheimer & Co. in October 2020, bringing scale and institutional backing while maintaining independent boutique positioning and partner-led engagement model. Oppenheimer affiliation provides access to broader capital markets, equity capital raising capabilities, and expanded PE/strategic buyer network.
Regulatory & Professional Standing
All principals are FINRA-registered securities representatives. The firm operates as an SEC-registered investment banker through Oppenheimer & Co. affiliation. Long track record of clean regulatory history and professional standing within middle-market investment banking community.